tetano
Editor, Senior Moderator
Med Rev (Berl)
. 2022 Apr 26;2(2):197-212.
doi: 10.1515/mr-2021-0024. Epub 2022 Apr 28.
Mass screening is a key component to fight against SARS-CoV-2 and return to normalcy
Zhaomin Feng[SUP] 1 [/SUP], Yi Zhang[SUP] 1 [/SUP], Yang Pan[SUP] 1 [/SUP], Daitao Zhang[SUP] 1 [/SUP], Lei Zhang[SUP] 2 [/SUP], Quanyi Wang[SUP] 1 [/SUP]
Affiliations
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had highly transmissible and pathogenic, which caused serious economic loss and hazard to public health. Different countries have developed strategies to deal with the COVID-19 pandemic that fit their epidemiological situations, capacities, and values. Mass screening combined with control measures rapidly reduced the transmission of the SARS-CoV-2 infection. The COVID-19 pandemic has dramatically highlighted the essential role of diagnostics capacity in the control of communicable diseases. Mass screening has been increasingly used to detect suspected COVID-19 cases and their close contacts, asymptomatic case, patients attending fever clinics, high-risk populations, employees, even all population to identify infectious individuals. Mass screening is a key component to fight against SARS-CoV-2 and return to normalcy. Here we describe the history of mass screening, define the scope of mass screening, describe its application scenarios, and discuss the impact and challenges of using this approach to control COVID-19. We conclude that through a comprehension screening program and strong testing capabilities, mass screening could help us return to normalcy more quickly.
Keywords: SARS-CoV-2; close contacts; diagnostics capacity; mass screening.
. 2022 Apr 26;2(2):197-212.
doi: 10.1515/mr-2021-0024. Epub 2022 Apr 28.
Mass screening is a key component to fight against SARS-CoV-2 and return to normalcy
Zhaomin Feng[SUP] 1 [/SUP], Yi Zhang[SUP] 1 [/SUP], Yang Pan[SUP] 1 [/SUP], Daitao Zhang[SUP] 1 [/SUP], Lei Zhang[SUP] 2 [/SUP], Quanyi Wang[SUP] 1 [/SUP]
Affiliations
- PMID: 35862506
- PMCID: PMC9274759
- DOI: 10.1515/mr-2021-0024
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had highly transmissible and pathogenic, which caused serious economic loss and hazard to public health. Different countries have developed strategies to deal with the COVID-19 pandemic that fit their epidemiological situations, capacities, and values. Mass screening combined with control measures rapidly reduced the transmission of the SARS-CoV-2 infection. The COVID-19 pandemic has dramatically highlighted the essential role of diagnostics capacity in the control of communicable diseases. Mass screening has been increasingly used to detect suspected COVID-19 cases and their close contacts, asymptomatic case, patients attending fever clinics, high-risk populations, employees, even all population to identify infectious individuals. Mass screening is a key component to fight against SARS-CoV-2 and return to normalcy. Here we describe the history of mass screening, define the scope of mass screening, describe its application scenarios, and discuss the impact and challenges of using this approach to control COVID-19. We conclude that through a comprehension screening program and strong testing capabilities, mass screening could help us return to normalcy more quickly.
Keywords: SARS-CoV-2; close contacts; diagnostics capacity; mass screening.